Login
Navigate Fool.com
Will MRK beat
the market?

Merck & Co., Inc. (NYSE: MRK)

Community Rating: 3 Stars: Appealing

58.36 0.36 (0.62%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.13
Previous Close $58.00
Daily Range $58.13 - $58.88
52-Week Range $44.62 - $59.84
Market Cap $170.5B
P/E Ratio 38.16
Dividend (Yield) $1.76 (3.0%)
Ex-Dividend Date
Dividend Pay Date
06/12/14
07/08/14
Volume 3,677,731
Average Daily Volume 8,437,685
Current FY EPS $3.49

How do you think MRK
will perform against the market?

Top MRK Bull/Bear Pitches

 

ErnestBludger (< 20)
Submitted August 28, 2013

It helps people - as well as making money - as shareholders, we have a chance to participate in the work that MRK does in saving lives with the drugs that we as shareholders fund. MRK presently has th … More

0 Replies Reply Report this Post
 

bryank2000 (0)
Submitted August 14, 2011

Terrible leadership + atrocious decision making has fostered a culture of fear and indifference. Not sure how that bolsters the pipeline.

0 Replies Reply Report this Post

News & Commentary Rss Feed

These 3 Dow Stocks Might be Too Richly Valued for You

Don't chase yield if it means settling for a company with substandard growth.

Johnson & Johnson Earnings: New Blockbuster Drug Olysio Lifts Sales But May Face Competition Soon

Are Insurers Playing Fair With HIV Patients?

Insurers Aetna (AET), Cigna (CI), and Humana (HUM) are on the hot seat over how much they'll pay for HIV drugs like those made by Gilead (GILD).

Do Massive Layoffs Really Benefit Companies?

Sometimes trying to do what's best for the company really doesn't help anyone.

How the Dow's Pharma Stocks Helped Boost Markets Friday

Merck and Johnson & Johnson both pushed higher, helping the Dow recover from Thursday's weakness.

Noteworthy ETF Inflows: VTI, T, IBM, MRK

Johnson & Johnson Earnings: New Blockbuster Drug Olysio Lifts Sales But May Face Competition Soon

S.Korea delays lifting ban on beef with feed additive

2 Reasons to Watch Bristol-Myers Squibb Co

Bristol-Myers Squibb is winning big in Japan, can they bring that success home?

1 Hidden Blockbuster Lurking in Merck's Pipeline?

Merck (MRK) is studying MK-1439 for use alongside Gilead's (GILD) blockbuster HIV drug Truvada.

See More MRK News...

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

More details for Merck Jobs
Merck reviews from employees

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks